Life Science REIT PLC Holding(s) in Company (1531Z)
January 09 2024 - 12:29PM
UK Regulatory
TIDMLABS
RNS Number : 1531Z
Life Science REIT PLC
09 January 2024
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BP5X4Q29
Issuer Name
LIFE SCIENCE REIT PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Hazelview Investments Inc.
City of registered office (if applicable)
Toronto
Country of registered office (if applicable)
Canada
4. Details of the shareholder
Name City of registered office Country of registered office
Hazelview Securities (US) LLC Toronto Canada
=========================== ==============================
Hazelview Securities Inc. Toronto Canada
=========================== ==============================
5. Date on which the threshold was crossed or reached
20-Dec-2023
6. Date on which Issuer notified
09-Jan-2024
7. Total positions of person(s) subject to the notification
obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 4.940000 0.000000 4.940000 17300631
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable) 5.980000 0.000000 5.980000
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on
which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting
ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
(DTR5.2.1)
GB00BP5X4Q29 17300631 4.940000
====================== ====================== ====================== ======================
Sub Total 8.A 17300631 4.940000%
============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights
instrument that may be acquired if
the instrument is
exercised/converted
Sub Total 8.B1
=========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect
according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
instrument period settlement rights
Sub Total 8.B2
========================================================= =================== ==================
9. Information in relation to the person subject to the
notification obligation
2. Full chain of controlled undertakings through which the
voting rights and/or the financial instruments are effectively held
starting with the ultimate controlling natural person or legal
entities (please add additional rows as necessary)
Ultimate controlling Name of controlled undertaking % of voting rights % of voting rights Total of both if it
person if it equals or is through financial equals or is higher
higher than the instruments if it than the notifiable
notifiable equals or is threshold
threshold higher than the
notifiable
threshold
Hazelview Universal-Investment-Luxembourg
Investments Inc. S.A. (Client of Hazelview
(Chain 1) Securities Inc.) 3.810000 0.000000 3.810000%
=================================== ================== ================== ===================
Hazelview Hazelview Securities (US) LLC
Investments Inc. (Subsidiary 2)
(Chain 2)
=================================== ================== ================== ===================
Hazelview Hazelview Securities Inc.
Investments Inc. (Subsidiary 1)
(Chain 1)
=================================== ================== ================== ===================
10. In case of proxy voting
Name of the proxy holder
Hazelview Securities Inc. and Hazelview Securities (US) LLC on
behalf of its client accounts.
The number and % of voting rights held
17300631, 4.94%
The date until which the voting rights will be held
Until the securities are sold.
11. Additional Information
12. Date of Completion
09-Jan-2024
13. Place Of Completion
Toronto, Ontario, Canada
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLUPUQPGUPCGMB
(END) Dow Jones Newswires
January 09, 2024 12:29 ET (17:29 GMT)
Life Science Reit (LSE:LABS)
Historical Stock Chart
From Apr 2024 to May 2024
Life Science Reit (LSE:LABS)
Historical Stock Chart
From May 2023 to May 2024